Recent News
- Radius Health & Menarini Group Provide Elacestrant Update
Target
- Radius Health Provides Business Update
Organizational
- Radius Health Announces Scientific Presentations on abaloparatide at ASBMR 2020 Annual Meeting
Includes
- Radius Health: Enrollment Completed for Phase 3 wearABLe trial
Innovative
- Radius Health to Participate in the Citi 15th Annual BioPharma Virtual Conference and Morgan Stanley Virtual 18th Annual Global Healthcare Conference
WALTHAM,
- Radius Health Provides Business Update
TYMLOS
- Sean Murphy joins Radius Health Board of Directors
WALTHAM,
- Radius Health Announces Second Quarter 2020 Operating Results
TYMLOS
- Radius Health to Announce Second Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Monday, August 10, 2020
WALTHAM,
- Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
Menarini